Thrombophilia, sometimes called hypercoagulability or a prothrombotic state, is an abnormality of blood coagulation that increases the risk of thrombosis, meaning blood clots forming in blood vessels. Such abnormalities can be identified in about half of the people who have an episode of thrombosis, such as deep vein thrombosis in the leg, that was not provoked by other causes. A significant proportion of the general population has a detectable thrombophilic abnormality, but most of these people develop thrombosis only in the presence of an additional risk factor. There is no specific treatment for most thrombophilias, although recurrent episodes of thrombosis may be an indication for long-term preventive anticoagulation. The first major form to be identified by medical science, antithrombin deficiency, was identified in 1965, while the most common abnormalities, including factor V Leiden, were described in the 1990s.
Facts
Classification
Body SystemLymphatic or Immune System 1 ICD-10 ChapterIII: Diseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism 2 Communicable or Non-communicable First Described Sources
1. National Library of Medicine: MeSH Descriptor Data: Thrombophilia
National Library of MedicineMeSH tree number C15.378.925Quote, MeSH tree number C15.378.925
A disorder of HEMOSTASIS in which there is a tendency for the occurrence of THROMBOSIS .
View the Source 2. Thrombophilia (Wikipedia)
Lead, first sentence
abnormality of blood coagulation that increases the risk of thrombosis
Lead, second paragraph
antithrombin deficiency, was identified in 1965
View the SourceReader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.